P09.12 Durable remission with tumor treating fields as adjuvant treatment for glioblastoma relapse in a patient with Grad IV hematotoxicity during initial temozolomide radiochemoth...

Por Hirt, C., Vorbau, C., Kirsch, M., Ranft, D., Schroeder, H. W. S., Dombrowski, F., Baldauf, J.
Publicado no Neuro Oncol (2017)

Immune Responses to RHAMM in Patients with Acute Myeloid Leukemia after Chemotherapy and Allogeneic Stem Cell Transplantation

Por Casalegno-Garduño, R., Meier, C., Schmitt, A., Spitschak, A., Hilgendorf, I., Rohde, S., Hirt, C., Freund, M., Pützer, B. M., Schmitt, M.
Publicado em 2012

Dual role of tumour-infiltrating T helper 17 cells in human colorectal cancer

Por Amicarella, F, Muraro, M G, Hirt, C, Cremonesi, E, Padovan, E, Mele, V, Governa, V, Han, J, Huber, X, Droeser, R A, Zuber, M, Adamina, M, Bolli, M, Rosso, R, Lugli, A, Zlobec, I, Terracciano, L, Tornillo, L, Zajac, P, Eppenberger-Castori, S, Trapani, F, Oertli, D, Iezzi, G
Publicado no Gut (2017)

High-dose methotrexate-based immuno-chemotherapy for elderly primary CNS lymphoma patients (PRIMAIN study)

Por Fritsch, K, Kasenda, B, Schorb, E, Hau, P, Bloehdorn, J, Möhle, R, Löw, S, Binder, M, Atta, J, Keller, U, Wolf, H-H, Krause, S W, Heß, G, Naumann, R, Sasse, S, Hirt, C, Lamprecht, M, Martens, U, Morgner, A, Panse, J, Frickhofen, N, Röth, A, Hader, C, Deckert, M, Fricker, H, Ihorst, G, Finke, J, Illerhaus, G
Publicado no Leukemia (2017)